HEALTH● LOW1h ago · Sep 25, 2026, 6:38 PM
Genentech's Gazyva gains indication for idiopathic nephrotic syndrome
Seeking Alpha Tech · global
Genentech's drug Gazyva has received a new indication for treating idiopathic nephrotic syndrome. This expands the therapeutic options available for patients with this specific medical condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH57m agoDoctor debunks myths about bone healthCBS NewsHEALTH1h agoBlood donation camp held in RaichurThe HinduHEALTH1h agoCarbide: Consumer Council cautions against harmful fruit ripening practiceVanguard NigeriaHEALTH1h agoFood safety inspections expose hygiene lapses at hotels, restaurants in VisakhapatnamThe Hindu